Emergent BioSolutions, Inc. - logo

Emergent BioSolutions, Inc. - Company & Market Research Reports

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.


Global CBRNE Detection Equipment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022 - Product Thumbnail Image

Global CBRNE Detection Equipment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • Report
From
Bispecific Antibodies: Clinical Trial Tracker - Product Thumbnail Image

Bispecific Antibodies: Clinical Trial Tracker

  • Clinical Trials
From
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024 - Product Thumbnail Image

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024

  • Report
  • 63 Pages
From
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 325414 - Product Thumbnail Image

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 325414

  • Report
  • 64 Pages
From
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 325414 - Product Thumbnail Image

Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 325414

  • Report
  • 65 Pages
From
European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of Europe - Product Thumbnail Image

European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of Europe

  • Report
  • 150 Pages
From
Global Biodefense Market 2017-2021 - Product Thumbnail Image

Global Biodefense Market 2017-2021

  • Report
  • 88 Pages
From
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments - Product Thumbnail Image

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

  • Report
  • 144 Pages
From
Biodefense Market Analysis By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Ebola, Hemorrhagic Fever) And Segment Forecasts To 2020 - Product Thumbnail Image

Biodefense Market Analysis By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Ebola, Hemorrhagic Fever) And Segment Forecasts To 2020

  • Report
  • 80 Pages
From
US Biodefense Market Outlook 2022 - Product Thumbnail Image

US Biodefense Market Outlook 2022

  • Report
  • 45 Pages
From
Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018 - Product Thumbnail Image

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018

  • Report
  • 36 Pages
From
Bacterial Pneumonia - Pipeline Review, H2 2016 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Review, H2 2016

  • Report
  • 212 Pages
From
Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016 - Product Thumbnail Image

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Pipeline Review, H2 2016

  • Report
  • 132 Pages
From
Respiratory Syncytial Virus Attachment Glycoprotein (G or RSV-G) - Pipeline Review, H1 2016 - Product Thumbnail Image

Respiratory Syncytial Virus Attachment Glycoprotein (G or RSV-G) - Pipeline Review, H1 2016

  • Report
  • 37 Pages
From
Bacterial Pneumonia - Pipeline Review, H1 2016 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Review, H1 2016

  • Report
  • 200 Pages
From
Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016 - Product Thumbnail Image

Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016

  • Report
  • 48 Pages
From
Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016 - Product Thumbnail Image

Respiratory Syncytial Virus Fusion Protein (RSV-F Protein) - Pipeline Review, H1 2016

  • Report
  • 121 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • Report
  • 390 Pages
From
Inflammatory Bowel Disease - Pipeline Review, H2 2015 - Product Thumbnail Image

Inflammatory Bowel Disease - Pipeline Review, H2 2015

  • Report
  • 1025 Pages
From
Loading Indicator
adroll